Jump to content


Photo

BCR-ABL1 Transcript Type Predicts Outcomes After Imatinib in CML


  • Please log in to reply
30 replies to this topic

#1 r06ue1

r06ue1

    Advanced Member

  • Members
  • PipPipPip
  • 426 posts
  • LocationEarth, Solar System, Milky Way, Local Group, Virgo Supercluster, Laniakea

Posted 12 May 2017 - 08:03 AM

BCR-ABL1 Transcript Type Predicts Outcomes After Imatinib in CML

http://www.cancerthe...article/655106/


08/2015 Initial PCR: 66.392%

12/2015 PCR: 1.573%

03/2016 PCR: 0.153%

06/2016 PCR: 0.070%

09/2016 PCR: 0.052%

12/2016 PCR: 0.036%

03/2017 PCR: 0.029%

06/2017 PCR: 0.028%

09/2017 PCR: 0.025%

12/2017 PCR: 0.018%

 

 

Taking Imatinib 400 mg


#2 Sandrea

Sandrea

    Advanced Member

  • Members
  • PipPipPip
  • 33 posts
  • LocationRussia, Siberia, Novosibirsk

Posted 12 May 2017 - 08:22 AM

 
I have e13a2, unfortunately, and my results are not very good.
PCR in 18 month 0.49%, in 21 month - 0.68%   :(

Diagnosed 1 April 2015. WBC 86000; b2a2 (p210) transcript 
on Hydrea for 2 months, then generic Gleevec 400mg (06/06/15)
CCyR in April 2016
 
12/22/2016  PCR:  0.49% (IS)           18 Month
03/29/2017  PCR:  0.68% (not IS)     21 Month
06/06/2017  PCR:  1.62% (not IS)     24 Month
06/20/2017  increased dose of imatinib to 600mg
10/30/2017  PCR:  0.15% (not IS)     28 Month
 

#3 scuba

scuba

    Advanced Member

  • Members
  • PipPipPip
  • 1,044 posts
  • LocationHouston, Texas

Posted 12 May 2017 - 08:54 AM

I have e13a2, unfortunately, and my results are not very good.
PCR in 18 month 0.49%, in 21 month - 0.68%   :(

Sandrea,

Switch drugs. Don't waste  time "waiting" for Gleevec to work better. Sprycel would be a better choice. You probably don't even need full dose (i.e. 70 mg starting is preferred) and will likely be able to drop dose after only a few months when Sprycel knocks down your CML to below 0.1%. Sprycel works differently than both Gleevec and Tasigna in targeting the bcr-abl breakpoints. It will likely have better impact on the e13a2 transcript than Gleevec.

Good luck.


Diagnosed 11 May 2011 (100% FiSH, 155% PCR)

with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein

 

Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate

6-8 grams Curcumin C3 complex.

 

2015 PCR: < 0.01% (M.D. Anderson scale)

2016 PCR: < 0.01% (M.D. Anderson scale) 

March        2017 PCR:     0.01% (M.D. Anderson scale)

June          2017 PCR:     "undetected"

September 2017 PCR:     "undetected"


#4 Sandrea

Sandrea

    Advanced Member

  • Members
  • PipPipPip
  • 33 posts
  • LocationRussia, Siberia, Novosibirsk

Posted 12 May 2017 - 10:06 AM

Thanks, scuba

but the change of drugs in our country is very difficult, delivering  imatinib is free (without payment), but second-generation drugs are very difficult to get, sometimes through law court. Some people wait for months and months, and it's unreal to buy - one  package costs almost my annual income. My hem doesn't  want to increase the dosage even, until she gets BMB results, and I can not change the doctor too...


Diagnosed 1 April 2015. WBC 86000; b2a2 (p210) transcript 
on Hydrea for 2 months, then generic Gleevec 400mg (06/06/15)
CCyR in April 2016
 
12/22/2016  PCR:  0.49% (IS)           18 Month
03/29/2017  PCR:  0.68% (not IS)     21 Month
06/06/2017  PCR:  1.62% (not IS)     24 Month
06/20/2017  increased dose of imatinib to 600mg
10/30/2017  PCR:  0.15% (not IS)     28 Month
 

#5 scuba

scuba

    Advanced Member

  • Members
  • PipPipPip
  • 1,044 posts
  • LocationHouston, Texas

Posted 12 May 2017 - 10:23 AM

Thanks, scuba

but the change of drugs in our country is very difficult, delivering  imatinib is free (without payment), but second-generation drugs are very difficult to get, sometimes through law court. Some people wait for months and months, and it's unreal to buy - one  package costs almost my annual income. My hem doesn't  want to increase the dosage even, until she gets BMB results, and I can not change the doctor too...

 

Health care in Russia is "single payer" government supplied - correct?

 

(the good news, however, is that your CML is below 1.0 % (PCR) and I assume your FISH (CML Cells counted under a microscope as a percentage) is zero. FISH = zero is more of a prognostication for long term survival than any other measure. Achieving that milestone (also called CCyR) is very important)


Diagnosed 11 May 2011 (100% FiSH, 155% PCR)

with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein

 

Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate

6-8 grams Curcumin C3 complex.

 

2015 PCR: < 0.01% (M.D. Anderson scale)

2016 PCR: < 0.01% (M.D. Anderson scale) 

March        2017 PCR:     0.01% (M.D. Anderson scale)

June          2017 PCR:     "undetected"

September 2017 PCR:     "undetected"


#6 thatguy

thatguy

    Advanced Member

  • Members
  • PipPipPip
  • 318 posts
  • LocationWild west

Posted 12 May 2017 - 11:04 AM

What country and type of health system do you have there?
3/25/2015- Dx'ed by FISH : 85% of cells dual-fusion signals, 7% with tri-fusion signals, WBC 212,000. Started Gleevec 400mg.... Calculated .93 SOKAL

08/17/2015- 14.793 % I.S P210 (quest)
10/15/2015- 3.313 % I.S (quest)
12/23/2015- 1.891 % I.S (quest)
1/07/2016- Tasigna 300mg 2x daily
1/14/2016- 4.414 % I.S P210- City Of Hope lab, mutation negative.
1/26/2016- 1.589 % I.S (quest)
2/22/2016- 1.719 % I.S (quest)
2/29/2016- 1.133 % I.S (quest)
3/03/2016- Tasigna 400mg 2x daily.
3/29/2016- 0.663 % I.S (quest)
4/27/2016- 0.781 % I.S (quest)
5/04/2016- 0.652 % I.S.(quest)
5/24/2016- 0.501 % I.S (quest)
6/28/2016-0.534 % I.S (quest)
7/15/2016-0.881 % I.S (quest)
7/22/2016- Bosulif 500mg
7/28/2016- t315i test- Negative
8/22/2016-0.432 % I.S (quest )
11/15/2016-0.325 % I.S (quest)
2/1/2017- .0445% i.s (genoptix)
5/6/2017- .0968% i.s (genoptix)
5/12/2017- .12 % i.s (quest).
6/4/2017- .083% i.s (quest)
6/11/2017- .0295% i.s (genoptix)
8/5/2017- .0501% i.s (genoptix)
11/6/2017- .0270% i.s (genoptix)

#7 Sandrea

Sandrea

    Advanced Member

  • Members
  • PipPipPip
  • 33 posts
  • LocationRussia, Siberia, Novosibirsk

Posted 12 May 2017 - 11:14 AM

Health care in Russia is "single payer" government supplied - correct?

 

Probably, yes... I don't really understand in this question, earlier the medicine was free for everyone, now everyone has received the identical insurance policy. I have never paid anywhere for two years of my illness, but monitoring in our region is low - one PCR per year and one BMB per year. I decided myself to do PCR additionally every three months and i paid for it's about 1/5 of my monthly earnings.  About FISH - this wasn't done for me, only BMB, in April 2016 there was a CCyR, and now BMB was in April 2017 and i wait for the results.  Thanks for the good news, I hope I will not lose the CCyR.
 


Diagnosed 1 April 2015. WBC 86000; b2a2 (p210) transcript 
on Hydrea for 2 months, then generic Gleevec 400mg (06/06/15)
CCyR in April 2016
 
12/22/2016  PCR:  0.49% (IS)           18 Month
03/29/2017  PCR:  0.68% (not IS)     21 Month
06/06/2017  PCR:  1.62% (not IS)     24 Month
06/20/2017  increased dose of imatinib to 600mg
10/30/2017  PCR:  0.15% (not IS)     28 Month
 

#8 scuba

scuba

    Advanced Member

  • Members
  • PipPipPip
  • 1,044 posts
  • LocationHouston, Texas

Posted 12 May 2017 - 12:56 PM

Probably, yes... I don't really understand in this question, earlier the medicine was free for everyone, now everyone has received the identical insurance policy. I have never paid anywhere for two years of my illness, but monitoring in our region is low - one PCR per year and one BMB per year. I decided myself to do PCR additionally every three months and i paid for it's about 1/5 of my monthly earnings.  About FISH - this wasn't done for me, only BMB, in April 2016 there was a CCyR, and now BMB was in April 2017 and i wait for the results.  Thanks for the good news, I hope I will not lose the CCyR.

 

You answered my question.

Reaching CCyR is your most important milestone. Fish = zero is the same thing as CCyR. 

 

It's good that you are aware of testing procedures and follow-up on your own. Feel free to post your BMB results for people here to comment. 


Diagnosed 11 May 2011 (100% FiSH, 155% PCR)

with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein

 

Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate

6-8 grams Curcumin C3 complex.

 

2015 PCR: < 0.01% (M.D. Anderson scale)

2016 PCR: < 0.01% (M.D. Anderson scale) 

March        2017 PCR:     0.01% (M.D. Anderson scale)

June          2017 PCR:     "undetected"

September 2017 PCR:     "undetected"


#9 Trey

Trey

    Advanced Member

  • PS Beta Group
  • PipPipPip
  • 1,705 posts
  • LocationSan Antonio, Texas

Posted 13 May 2017 - 09:57 AM

I have some degree of doubt about the e13a2 (b2a2) being significantly more of a problem than the e14a2 (b3a2).  There are far too many variables to conclude that is a serious issue, although it could be a small factor in some if combined with other issues like drug uptake, cellular uptake, minor variations in the Philadelphia Chromosome.  Overall, most people with e13a2 do just as well as those with e14a2.  If the breakpoint was the only issue in drug response that would not be the case.



#10 kat73

kat73

    Advanced Member

  • Members
  • PipPipPip
  • 884 posts
  • LocationWashington, DC area

Posted 15 May 2017 - 09:48 AM

How do you find out which of these two you have?  I never had a bone marrow test done.  I don't see it mentioned anywhere in my paperwork.


Dx July 2009 on routine physical.  WBC 94.  Started Gleevec 400 mg Sept 2009.  MMR at 2yrs.  Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved.  Kidney issues developed because of Gleevec.  Switched to Sprycel 70 mg in Aug 2011.  Above side effects disappeared or improved.  Have been MR3.5 - 4.5 ever since.  Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017.  After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS.  Pleural effusion returned within a couple of months, same as before (moderate, left side only).  Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved.  At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.


#11 cmljax

cmljax

    Advanced Member

  • Members
  • PipPipPip
  • 115 posts

Posted 15 May 2017 - 01:24 PM

I think the only way to know is to have a bone marrow biopsy (BMB).  How did you ever get away without one? It is not worth the pain of having a BMB just to find out which breakpoint you have - like Trey said, it's not that big of a deal anyway.  My one and only BMB so far was AWFUL.  Save yourself the agony if you can Kat.


Dx 9/26/16 WBC 28800; platelets 749; FISH 97% PCR 43%

Tasigna 600MG per day

October 2016                     PCR 22% IS

November 2016                 PCR 5.8% IS

December 2016                 PCR 0.1% IS  MMR!!

March 10, 2017                 PCR 0.006% IS  MR 4.22

Tasigna 450MG per day

April 5, 2017                      PCR <.003% IS

June 5, 2017                     PCR <.003% IS (dose reduction validated!!!)

Tasigna 300MG per day starting June 15, 2017

6-day drug break starting June 20, 2017 due to multiple AE's

July 24, 2017                     PCR <.003% IS

September 18, 2017          Negative, AKA PCRU

Tasigna 150mg per day starting 9/18/17

October 30, 2017               Negative

December 11, 2017           Negative


#12 kat73

kat73

    Advanced Member

  • Members
  • PipPipPip
  • 884 posts
  • LocationWashington, DC area

Posted 15 May 2017 - 02:47 PM

Yes, I have always considered myself lucky to have skipped that!  I don't know why one wasn't ordered.  It was 2009 and I was seen by a specialist with decades of experience, at a prestigious large hospital center.  I think my bloodwork was pretty straightforwardly pointing to uncomplicated CML or something.  I did have something called a Cytogenetics Karyotype Report (using peripheral blood) and it said 20 metaphases were counted and analyzed, and 3 were karyotyped with a banding level of up to 400.  Whatever all that means.  There was also a nice little photograph of my squiggly chromosome pairs.  I also remember asking if I had to have a BMB, and the doc paused and looked at the ceiling and answered, "I don't think so," as if he were going to wait and see or something.  There was never any more discussion about it.  When I switched oncs two years later and went to a brand new place, I asked again, and the new guy said no, I didn't need one.  So, although over the years I have been curious, I decided I wasn't all THAT curious and that I wouldn't be the one to bring it up ;)  


Dx July 2009 on routine physical.  WBC 94.  Started Gleevec 400 mg Sept 2009.  MMR at 2yrs.  Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved.  Kidney issues developed because of Gleevec.  Switched to Sprycel 70 mg in Aug 2011.  Above side effects disappeared or improved.  Have been MR3.5 - 4.5 ever since.  Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017.  After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS.  Pleural effusion returned within a couple of months, same as before (moderate, left side only).  Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved.  At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.


#13 Sandrea

Sandrea

    Advanced Member

  • Members
  • PipPipPip
  • 33 posts
  • LocationRussia, Siberia, Novosibirsk

Posted 15 May 2017 - 03:12 PM

BMB is not needed to know the breakpoint, usually it is indicated in the results of PCR analysis, for example, like this: "A b2a2 BCR-ABL1 fusion transcript coding for the 210kDa BCR-ABL1 fusion protein is detected by quantitative real-time RT-PCR"
http://community.lls...al/#entry174635


Diagnosed 1 April 2015. WBC 86000; b2a2 (p210) transcript 
on Hydrea for 2 months, then generic Gleevec 400mg (06/06/15)
CCyR in April 2016
 
12/22/2016  PCR:  0.49% (IS)           18 Month
03/29/2017  PCR:  0.68% (not IS)     21 Month
06/06/2017  PCR:  1.62% (not IS)     24 Month
06/20/2017  increased dose of imatinib to 600mg
10/30/2017  PCR:  0.15% (not IS)     28 Month
 

#14 gerry

gerry

    Advanced Member

  • Members
  • PipPipPip
  • 1,035 posts

Posted 15 May 2017 - 05:05 PM

The article doesn't indicate that you will lose CCyR only that you turn into a turtle in regard to future milestones. But if you read a number of the threads, turtles can eventually get to MMR and even PCRU.

#15 gerry

gerry

    Advanced Member

  • Members
  • PipPipPip
  • 1,035 posts

Posted 15 May 2017 - 05:10 PM

No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib.

https://www.ncbi.nlm...pubmed/28083711

#16 Trey

Trey

    Advanced Member

  • PS Beta Group
  • PipPipPip
  • 1,705 posts
  • LocationSan Antonio, Texas

Posted 15 May 2017 - 06:10 PM

By the way, I have both e13a2 and e14a2, and my e13a2 went undetectable faster than my e14a2.  So my personal experience is that it was not an issue for me. 



#17 Melanie

Melanie

    Advanced Member

  • Members
  • PipPipPip
  • 219 posts
  • LocationArizona

Posted 15 May 2017 - 11:25 PM

By the way, I have both e13a2 and e14a2, and my e13a2 went undetectable faster than my e14a2. So my personal experience is that it was not an issue for me.


Dx - 05/2011; PCR: 15.04; Fish: 87% Slow responder due to pancytopenia. Current - Bosulif - Nov: 2012, Mar 2016 lowered to 300 mg. 07/16 back to 400 mg. Clinical trial drug, Promacta, Feb 2013, for low Platelets.
CyCR - Aug 2014, Positive for 1 chromosome Sep 2015. PCR: 12.77 in Oct, 2012 to 0.04 (MDA) in Mar, 2016. 4/2016 - 0.126 (Local lab (IS); 05/2016 - 0.195 (local); 6/2016 - 0.07 (MDA); 7/2016 - 0.03 (local) 9/13/2016 - 0.16 (MDA); 9/26/2016 - 0.31 (MDA); 11/2016 - 0.012 (local); 01/2017 - 0.24 (MDA); 04/2017 - 0.09 (MDA); Cytogenetics show der(1:7)(q10;p10)7 chromosome mutation. Repeat of Sep 2015. PCR - 6/2017- 0.035 (local); 10/2017- 0.02 (MDA)

#18 Melanie

Melanie

    Advanced Member

  • Members
  • PipPipPip
  • 219 posts
  • LocationArizona

Posted 15 May 2017 - 11:33 PM

I also had both e13a2 and e14a2, and my e13a2 finally went undetectable about a year ago. Still waiting for the e14a2, but hoping it will disappear soon!
Dx - 05/2011; PCR: 15.04; Fish: 87% Slow responder due to pancytopenia. Current - Bosulif - Nov: 2012, Mar 2016 lowered to 300 mg. 07/16 back to 400 mg. Clinical trial drug, Promacta, Feb 2013, for low Platelets.
CyCR - Aug 2014, Positive for 1 chromosome Sep 2015. PCR: 12.77 in Oct, 2012 to 0.04 (MDA) in Mar, 2016. 4/2016 - 0.126 (Local lab (IS); 05/2016 - 0.195 (local); 6/2016 - 0.07 (MDA); 7/2016 - 0.03 (local) 9/13/2016 - 0.16 (MDA); 9/26/2016 - 0.31 (MDA); 11/2016 - 0.012 (local); 01/2017 - 0.24 (MDA); 04/2017 - 0.09 (MDA); Cytogenetics show der(1:7)(q10;p10)7 chromosome mutation. Repeat of Sep 2015. PCR - 6/2017- 0.035 (local); 10/2017- 0.02 (MDA)

#19 Sandrea

Sandrea

    Advanced Member

  • Members
  • PipPipPip
  • 33 posts
  • LocationRussia, Siberia, Novosibirsk

Posted 16 May 2017 - 02:09 AM

Thanks, Gerry and Trey, this article is a little calming.

I'm worried because my PCR is coming near 1 in almost 2 years of treatment, and 24% of myelocytes were in the last myelogram (the norm is up to 12%), it's more than I had at diagnosis even. I had relatively good conditions at the start (normal size of the spleen, no blasts in the blood and 1.6% in the bone marrow, few basophils-3%) and so I hoped that the response would be better and faster. Well, we have what we have.


Diagnosed 1 April 2015. WBC 86000; b2a2 (p210) transcript 
on Hydrea for 2 months, then generic Gleevec 400mg (06/06/15)
CCyR in April 2016
 
12/22/2016  PCR:  0.49% (IS)           18 Month
03/29/2017  PCR:  0.68% (not IS)     21 Month
06/06/2017  PCR:  1.62% (not IS)     24 Month
06/20/2017  increased dose of imatinib to 600mg
10/30/2017  PCR:  0.15% (not IS)     28 Month
 

#20 kat73

kat73

    Advanced Member

  • Members
  • PipPipPip
  • 884 posts
  • LocationWashington, DC area

Posted 16 May 2017 - 03:31 PM

Sandrea - I do see that notation in what few very old PCR reports I have - I just thought it was boiler plate language, especially since it mentioned both.  I just thought it was more gobbledy-gook about what the CML looks like to the test.  But now, I guess that it was telling me I have both.  How can you have two breakpoints??!!?  That sounds like a bad thing.  But I'll never be able to follow whether one disappears, as I never actually see my PCR reports - I have to rely on the onc's emailing me the magic number.  It's a computer thing, and yes, I've spoken to the institution's top IT administrator who assured me they'd fix it, but they haven't and it's going on years now.  They just say have the doc copy it and send it, but he refuses, as he has about a billion patients he'd have to do it for.


Dx July 2009 on routine physical.  WBC 94.  Started Gleevec 400 mg Sept 2009.  MMR at 2yrs.  Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved.  Kidney issues developed because of Gleevec.  Switched to Sprycel 70 mg in Aug 2011.  Above side effects disappeared or improved.  Have been MR3.5 - 4.5 ever since.  Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017.  After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS.  Pleural effusion returned within a couple of months, same as before (moderate, left side only).  Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved.  At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.





1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users